|
US6320041B1
(en)
|
2001-04-13 |
2001-11-20 |
Trilink Biotechnologies, Inc. |
Pre-activated carbonyl linkers for the modification of oligonucleotides
|
|
US8153141B2
(en)
|
2002-04-04 |
2012-04-10 |
Coley Pharmaceutical Gmbh |
Immunostimulatory G, U-containing oligoribonucleotides
|
|
US20050239733A1
(en)
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
|
WO2005097993A2
(en)
*
|
2004-02-19 |
2005-10-20 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral rna oligonucleotides
|
|
WO2006063152A2
(en)
*
|
2004-12-08 |
2006-06-15 |
3M Innovative Properties Company |
Immunostimulatory combinations and methods
|
|
EP1819365B1
(en)
|
2004-12-09 |
2014-07-02 |
Alnylam Pharmaceuticals Inc. |
Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs
|
|
CN101160401A
(zh)
*
|
2005-02-24 |
2008-04-09 |
科勒制药集团公司 |
免疫刺激寡核苷酸
|
|
EP1764107A1
(en)
*
|
2005-09-14 |
2007-03-21 |
Gunther Hartmann |
Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides
|
|
US8076068B2
(en)
|
2005-09-14 |
2011-12-13 |
Gunther Hartmann |
Method for determining immunostimulatory activity of RNA oligonucleotides
|
|
KR20080059595A
(ko)
*
|
2005-09-27 |
2008-06-30 |
콜리 파마슈티칼 게엠베하 |
어댑터 올리고뉴클레오티드를 사용하는 ｔｌｒ-매개 면역반응의 조절
|
|
PL1957647T3
(pl)
*
|
2005-11-25 |
2015-07-31 |
Zoetis Belgium S A |
Oligorybonukleotydy immunostymulujące
|
|
CN101331229B
(zh)
*
|
2005-11-25 |
2012-08-29 |
科勒制药股份公司 |
免疫刺激性寡核糖核苷酸
|
|
EP2021008B1
(en)
*
|
2006-04-07 |
2015-12-02 |
Idera Pharmaceuticals, Inc. |
Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
|
|
AU2007268075C1
(en)
|
2006-06-01 |
2013-03-07 |
Trilink Biotechnologies |
Chemically modified oligonucleotide primers for nucleic acid amplification
|
|
AU2007280690C1
(en)
*
|
2006-07-31 |
2012-08-23 |
Curevac Gmbh |
Nucleic acid of formula (I): GIXmGn, or (II): CIXmCn, in particular as an immune-stimulating agent/adjuvant
|
|
EP3342415B1
(en)
*
|
2006-08-08 |
2022-01-26 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Structure and use of 5' phosphate oligonucleotides
|
|
WO2008019486A1
(en)
|
2006-08-16 |
2008-02-21 |
Protiva Biotherapeutics, Inc. |
Nucleic acid modulation of toll-like receptor-mediated immune stimulation
|
|
CA2692161C
(en)
*
|
2007-07-09 |
2015-09-29 |
Idera Pharmaceuticals, Inc. |
Stabilized immune modulatory rna (simra) compounds
|
|
JP5753382B2
(ja)
*
|
2007-11-06 |
2015-07-22 |
アディウティーダ ファーマシューティカルズ ゲーエムベーハー |
修飾されたオリゴリン酸基を含有する免疫賦活オリゴリボヌクレオチドアナログ
|
|
US20100047188A1
(en)
*
|
2008-08-04 |
2010-02-25 |
Idera Pharmaceuticals, Inc. |
Modulation of toll-like receptor 8 expression by antisense oligonucleotides
|
|
US9631227B2
(en)
|
2009-07-06 |
2017-04-25 |
Trilink Biotechnologies, Inc. |
Chemically modified ligase cofactors, donors and acceptors
|
|
EP3191591A1
(en)
*
|
2014-09-12 |
2017-07-19 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting complement component c5 and methods of use thereof
|
|
WO2016205323A1
(en)
*
|
2015-06-18 |
2016-12-22 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotde agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof
|
|
ES2964690T3
(es)
|
2015-09-21 |
2024-04-09 |
Trilink Biotechnologies Llc |
Método para sintetizar ARN con caperuza 5'
|
|
WO2017100587A1
(en)
*
|
2015-12-09 |
2017-06-15 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting programmed cell death 1 ligand 1 (pd-l1) and methods of use thereof
|
|
WO2018184003A1
(en)
|
2017-03-31 |
2018-10-04 |
Dana-Farber Cancer Institute, Inc. |
Modulating dsrna editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferon
|
|
US11603532B2
(en)
*
|
2017-06-02 |
2023-03-14 |
Wave Life Sciences Ltd. |
Oligonucleotide compositions and methods of use thereof
|
|
CN115916978A
(zh)
|
2020-05-19 |
2023-04-04 |
哈德森医学研究所 |
寡核苷酸
|